Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GLA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GLA is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, contributes to. Associated with ALS, Als, Amyotrophic Lateral Sclerosis. Connected to 156 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | GLA |
| Aliases | Page for GLA Gene |
| Protein Type | Hydrolase |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | 50 kDa |
| Pathways | autophagy pathway, epigenetic regulation, oxidative stress response |
| Ensembl ID | ENSG00000102393 |
| GeneCards | GLA |
| Human Protein Atlas | GLA |
| Associated Diseases | Als, Amyotrophic Lateral Sclerosis, Ataxia, Cancer, Cardiovascular |
| Known Drugs/Compounds | rapamycin |
| Interactions | AR, ATG, ATG10, ATG12, ATP6AP2, CALCINEURIN |
| KG Connections | 281 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
GLA["GLA
(Alpha-galactosidase A)"]
%% Autophagy pathway
GLA -->|"activates"| ATG12["ATG12
(Autophagy protein)"]
ATG12 -->|"promotes"| Autophagy["Autophagy
(Cellular clearance)"]
GLA -->|"associated_with"| BECN1["BECN1
(Beclin-1)"]
BECN1 -->|"regulates"| Autophagy
%% Calcium signaling and cellular stress
GLA -->|"activates"| CALCINEURIN["CALCINEURIN
(Protein phosphatase)"]
CALCINEURIN -->|"regulates"| Calcium_Signaling["Calcium
Signaling"]
%% Protein quality control
GLA -->|"associated_with"| STUB1["STUB1
(CHIP ubiquitin ligase)"]
GLA -->|"associated_with"| HSPB8["HSPB8
(Heat shock protein)"]
STUB1 -->|"promotes"| Protein_Degradation["Protein
Degradation"]
HSPB8 -->|"maintains"| Protein_Folding["Protein
Folding"]
%% RNA processing and neurodegeneration
GLA -->|"associated_with"| TARDBP["TARDBP
(TDP-43)"]
TARDBP -->|"dysfunction"| RNA_Processing["RNA Processing
Defects"]
%% Metabolic regulation
GLA -->|"associated_with"| PPARGC1A["PPARGC1A
(PGC-1alpha)"]
PPARGC1A -->|"regulates"| Mitochondrial_Function["Mitochondrial
Function"]
%% Neurodegenerative diseases
GLA -->|"activates"| Neurodegeneration["Neurodegeneration"]
Neurodegeneration -->|"manifests_as"| ALS["Amyotrophic
Lateral Sclerosis"]
Neurodegeneration -->|"manifests_as"| Parkinsons["Parkinson's
Disease"]
Neurodegeneration -->|"manifests_as"| Huntingtons["Huntington's
Disease"]
Neurodegeneration -->|"manifests_as"| Ataxia["Ataxia"]
%% Cellular dysfunction pathways
Protein_Degradation -->|"failure_leads_to"| Neurodegeneration
RNA_Processing -->|"impairment_causes"| Neurodegeneration
Mitochondrial_Function -->|"dysfunction_promotes"| Neurodegeneration
Calcium_Signaling -->|"dysregulation_contributes"| Neurodegeneration
%% Styling
style GLA fill:#006494
style Autophagy fill:#1b5e20
style Protein_Folding fill:#1b5e20
style ATG12 fill:#4a1a6b
style BECN1 fill:#4a1a6b
style STUB1 fill:#4a1a6b
style HSPB8 fill:#4a1a6b
style PPARGC1A fill:#4a1a6b
style CALCINEURIN fill:#4a1a6b
style TARDBP fill:#ef5350
style RNA_Processing fill:#ef5350
style Neurodegeneration fill:#ef5350
style ALS fill:#5d4400
style Parkinsons fill:#5d4400
style Huntingtons fill:#5d4400
style Ataxia fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| RNA | activates | gene | 0.70 |
| Parkinson's disease | activates | disease | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| Ischemia | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Cardiovascular | associated_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Ataxia | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Huntington | associated_with | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Cardiovascular | regulates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Spinocerebellar Ataxia | associated_with | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Neuroblastoma | associated_with | disease | 0.65 |
| Tumor | contributes_to | disease | 0.65 |
| Autism | contributes_to | disease | 0.65 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | gene | 0.60 |
| Tdp-43 | associated_with | pathway | 0.60 |
| Sod1 | associated_with | pathway | 0.60 |
| BCL2L1 | associated_with | gene | 0.60 |
| TDP-43 | associated_with | gene | 0.60 |
| P62 | associated_with | gene | 0.60 |
| Neural Progenitor | associated_with | cell_type | 0.60 |
| Rb | associated_with | protein | 0.60 |
| neurodegeneration | activates | disease | 0.60 |
| cerebellum | expressed_in | brain_region | 0.60 |
| Chaperone | associated_with | pathway | 0.60 |
| Amyloid | associated_with | pathway | 0.60 |
| GENES | activates | gene | 0.60 |
| RAS | activates | gene | 0.60 |
| epigenetic regulation | participates_in | pathway | 0.60 |
| SOD1 | associated_with | gene | 0.60 |
| ATP6AP2 | associated_with | gene | 0.60 |
| RAS | associated_with | gene | 0.60 |
| Sphingolipid | contributes_to | pathway | 0.60 |
| Lipid Metabolism | contributes_to | pathway | 0.60 |
| HUNTINGTON | associated_with | gene | 0.60 |
| CGAS-STING | expressed_in | gene | 0.60 |
| DNA | inhibits | gene | 0.60 |
| NEURON | expressed_in | gene | 0.60 |
| Innate Immunity | inhibits | pathway | 0.60 |
| Cgas-Sting | expressed_in | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| AR | activates | gene | 0.70 |
| rapamycin | targets | drug | 0.70 |
| ATG | activates | gene | 0.70 |
| AND | expressed_in | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| RNA | associated_with | gene | 0.60 |
| GABA | associated_with | gene | 0.60 |
| CYP19A1 | associated_with | gene | 0.60 |
| MAGI2 | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| ULK1 | associated_with | gene | 0.60 |
| RAB9A | associated_with | gene | 0.60 |
| BCL2L1 | associated_with | gene | 0.60 |
| GABARAP | associated_with | gene | 0.60 |
| PIK3C3 | associated_with | gene | 0.60 |
| AMBRA1 | associated_with | gene | 0.60 |
| CTSD | associated_with | gene | 0.60 |
| HDAC6 | associated_with | gene | 0.60 |
| LAMP2 | associated_with | gene | 0.60 |
| UVRAG | associated_with | gene | 0.60 |
| VDAC2 | associated_with | gene | 0.60 |
| ARSA | associated_with | gene | 0.60 |
| AMBRA1 | activates | entity | 0.60 |
| APP | activates | entity | 0.60 |
| BCL2L1 | activates | entity | 0.60 |
| CTSD | activates | entity | 0.60 |
| ESR1 | activates | entity | 0.60 |
| ESR2 | activates | entity | 0.60 |
| FYCO1 | activates | entity | 0.60 |
| GABARAP | activates | entity | 0.60 |
| GALC | inhibits | gene | 0.60 |
| ATG | associated_with | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| PPP3 | associated_with | gene | 0.60 |
| AMPK | associated_with | gene | 0.60 |
| LC3B | associated_with | gene | 0.60 |
| TREHALOSE | activates | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| PRESENILIN | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| AMYLOID | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| MYELIN | contributes_to | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| DSDNA | inhibits | gene | 0.60 |
| ALS | activates | entity | 0.60 |
| AMPK | activates | entity | 0.60 |
| CYP19A1 | activates | gene | 0.60 |
| GABA | activates | gene | 0.60 |
| TARDBP | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GLA in their description or question text
No additional research found